NeuroAlign software

FDA 510(k) K231897 · Medivis, Inc.

Substantially Equivalent

510(k) numberK231897

Submission

Device name
NeuroAlign software
Applicant
Medivis, Inc.
New York, NY, US
Received
June 28, 2023
Decision date
October 21, 2025
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
HAW – Neurological Stereotaxic Instrument
Device class
Class II (moderate risk)
Regulation
21 CFR 882.4560
Specialty
Neurology

Other 510(k)s with product code HAW

510(k)DeviceApplicantDecision
K253856Geniant Cranial (Navigated Neurosurgical Positioning Robot)HAW · Traditional Koh Young Technology, Inc.09/10/2026SE
K261932Leksell® Vantage Stereotactic SystemHAW · Traditional Elekta Solutions AB08/05/2026SE
K253663Zeta Navigation SystemHAW · Traditional Zeta Surgical, Inc.05/01/2026SE
K253379Stealth AXiS Cranial clinical applicationHAW · Traditional Medtronic Navigation, Inc.03/26/2026SE
K251317SOLOPASS 2.0 SystemHAW · Traditional Intravent Medical Partners09/05/2025SE
K250893Ball Joint Guide Array (66295)HAW · Traditional Bayer Medical Care, Inc.09/04/2025SE
K250505Ez-FiducialsHAW · Traditional Phasor Health, LLC07/09/2025SE
K242575Stereotaxic Guiding Surgical Devices, NaoTrac SHAW · Traditional Brain Navi Biotechnology Co., Ltd.05/23/2025SE
K241327Navient Image Guide Navigation System (955-NC-NC), CranialHAW · Traditional Claronav02/05/2025SE
K243698Alignment System Cranial, with Alignment Software Cranial with LITT; Cirq Alignment…HAW · Traditional Brainlab AG01/28/2025SE

More from Brainlab AG

510(k)DeviceDecision
K233725Spine Navigation SystemOLO · Traditional 07/26/2024SE
K190764SurgicalARLLZ · Traditional 05/13/2019SE

Questions and answers

When was NeuroAlign software cleared by the FDA?

NeuroAlign software (K231897) received a 510(k) decision of Substantially Equivalent on October 21, 2025, 846 days after the submission was received.

What is the product code of K231897?

The FDA product code is HAW – Neurological Stereotaxic Instrument, a Class II (moderate risk) device regulated under 21 CFR 882.4560.